Skip to main content
    C

    Celularity Inc (CELU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.33
    +0.02 (+1.53%)

    Market Cap: $46.08M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(9/17)
    Avg Surprise
    -203.09%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Sep 29
    		$0.02N/AN/ABeat+103.3%
    Mar 26
    Reported Apr 30
    		$0.02N/AN/ABeat+103.7%
    Sep 25
    Reported Nov 14
    		$-0.88$-1.50+41.33%Beat-20.1%
    Jun 25
    Reported Aug 29
    		$-1.02$-0.75-36.13%Miss-243.9%
    Mar 25
    Reported May 8
    		$-0.60$-0.15-300.00%Miss+41.6%
    Dec 24
    Reported Feb 26
    		$-0.59N/AN/ABeat-18.9%
    Sep 24
    Reported Nov 7
    		$-0.73$-1.40+47.68%Beat-46.9%
    Jun 24
    Reported Jul 31
    		$-0.30$0.00N/ABeat+89.0%
    Mar 24
    Reported May 14
    		$-1.03$-1.40+26.66%Beat+75.0%
    Dec 23
    Reported Jan 2
    		$-0.50$-0.03-1566.67%Miss-108.3%
    Sep 23
    Reported Dec 5
    		$-0.50$-0.03-1561.67%Miss+80.8%
    Jun 23
    Reported Aug 14
    		$-2.70$-0.30-800.00%Miss-184.4%
    Mar 23
    Reported May 22
    		$-4.10$-2.40-70.83%Miss+14.6%
    Dec 22
    Reported Mar 31
    		$-0.24$-0.25+4.00%Beat-700.0%
    Sep 22
    Reported Nov 10
    		$-2.59$-3.05+15.08%Beat-164.8%
    Jun 22
    Reported Aug 9
    		$3.20$-2.60+223.08%Beat+219.0%
    Mar 22
    Reported May 16
    		$-4.80$-2.80-71.43%Miss-293.5%
    Dec 21
    Reported Mar 31
    		$-0.03N/A+90.32%Beat+76.9%
    Sep 21
    Reported Nov 12
    		$4.00$-3.45+215.94%Beat+400100.0%
    Jun 21
    Reported Aug 16
    		$-2.69$-0.16-1581.25%Miss-13350.0%
    Mar 21
    Reported May 24
    		$2.48$-0.14+1871.43%Beat+1966.7%
    Dec 20
    Reported Mar 4
    		$-0.13N/AN/ABeat-244.4%
    Sep 20
    Reported Nov 16
    		$-0.00N/AN/ABeat-100.8%
    Jun 20
    Reported Aug 12
    		$-0.02N/AN/ABeat-200.0%
    Mar 20
    Reported May 14
    		$0.12N/AN/ABeat+500.0%
    Dec 19
    Reported Mar 23
    		$0.09N/AN/ABeat-
    Sep 19
    Reported Nov 13
    		$0.13N/AN/ABeat-
    Jun 19
    Reported Aug 7
    		$0.02$0.00N/ABeat-
    Mar 19
    Reported Apr 26
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-263.50%
    ROE-6367.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-18.91x
    Current Ratio0.09xQuick Ratio0.08x
    Trading Statistics
    Beta0.78Avg Volume139.10K
    52-Week High$2.5552-Week Low$0.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.49
    SMA 20$1.40
    SMA 50$1.26
    SMA 200$1.10
    EMA 10$1.42
    EMA 20$1.41
    EMA 50$1.28
    EMA 200$1.23

    MACD

    Line: 0.03Signal: 0.06Hist: -0.03

    ADX

    ADX: 28.6+DI: 26.8-DI: 22.0

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down36.0
    PSAR$1.79

    Bollinger Bands

    Upper Band$1.68
    Lower Band$1.12
    %B Position4021%(Upper)
    Band Width0.38

    RSI (14-Day)

    Neutral
    47.4

    Momentum Oscillators

    Stoch %K18.9
    Stoch %D34.2
    Williams %R-88.7
    ROC (10d)-3.6%
    Momentum-0.05
    CCI (20d)-51.0
    MFI (14d)53.3

    Volatility Measures

    ATR (14d)$0.14(10.9%)
    StdDev (20d)0.14
    Hist Vol108.0%(High)

    Volume Flow

    VWAP$1.31
    OBV223.3M
    AD Line88.8M
    CMF (20d)0.070

    Volume Metrics

    Avg Vol (20d)140.1K
    Vol Ratio0.2x(Low)
    VWMA (20d)$1.42

    Pivot Points

    R3$1.52
    R2$1.46
    R1$1.39
    Pivot Point$1.33
    S1$1.26
    S2$1.20
    S3$1.13

    Advanced Oscillators

    TSI5.99
    Ultimate Osc39.6
    KST275.44

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.85M$4.10M$4.10M$5.28M$5.74M$18.13M$18.13M$9.30M$12.11M$14.68M$3.79M$3.79M
    Cost of Revenue$1.06M$-4,452,000$7.37M$2.02M$5.24M$7.34M$7.34M$3.88M$9.61M$1.64M$3.60M$3.60M
    Gross Profit$2.79M$8.56M$-3,270,000$3.27M$494,000$10.79M$10.79M$5.41M$2.50M$13.04M$184,000$184,000
    Operating Expenses$12.92M$30.61M$26.16M$16.17M$16.36M$20.07M$27.61M$16.94M$-10,812,000$22.06M$99.44M$20.09M
    R&D$2.99M$3.35M$3.35M$4.60M$3.35M$3.83M$3.83M$3.92M$108.07M$5.84M$5.18M$5.18M
    SG&A$0$0$15.06M$9.31M$12.63M$16.04M$16.06M$12.65M$13.02M$14.03M$13.07M$10.75M
    Operating Income$-10,133,000$-22,058,000$-22,058,000$-12,900,000$-15,864,000$-9,280,000$-9,473,000$-11,527,000$13.31M$-7,376,000$-99,256,000$-16,299,000
    Interest Income$0$0$62,000$62,000$62,000$76,000$77,000$77,000$67,000$110,000$115,000$23,000
    Interest Expense$352,000$897,000$897,000$1.48M$1.94M$1.81M$1.81M$1.75M$663,000$1.15M$971,000$971,000
    Income Before Tax$675,000$-24,359,000$-24,359,000$-23,076,000$-24,524,000$-13,293,000$-13,293,000$-16,098,000$9.56M$-22,013,000$-93,876,000$-93,876,000
    Income Tax Expense$0$3,000$0$-3,000$0$13.49M$0$-13,489,000$10,000$0$2.11M$0
    Net Income$675,000$-24,362,000$-24,362,000$-23,073,000$-24,524,000$-13,293,000$-13,293,000$-16,098,000$9.55M$-22,013,000$-93,876,000$-93,876,000
    EBITDA$1.60M$-21,659,000$-21,659,000$-19,775,000$-20,747,000$-7,597,000$-9,605,000$-12,452,000$-8,550,000N/A$-90,562,000N/A
    EBIT$0$-23,462,000$-23,462,000$-21,599,000$-22,581,000$-9,473,000$-11,481,000$-14,346,000$-10,846,000N/A$-92,905,000N/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CELU

    News

    Form 8K Celularity Inc Class A For: 29 September By Investing.com

    This article reports on a Form 8K filing by Celularity Inc Class A, dated September 29, 2026. The brief piece includes the company's stock symbol CELU and indicates that the filing was published on Investing.com.

    Investing.com Nigeria•9/29/26•Neutral

    A trust can name two of Celularity's (CELU) five directors under a financing deal.

    Celularity Inc. issued a $3.21 million senior secured convertible promissory note and five-year warrants to the Philip & Daniele Barach Family Trust. The financing agreement grants the Trust the right to designate two...

    Stock Titan•9/28/26•Neutral

    Celularity Director Philip Barach Updates Convertible Notes and Warrants, Acquires New Securities

    Philip Alan Barach, a director and 10% stakeholder of Celularity Inc (NASDAQ:CELU), has updated his holdings by amending existing convertible notes and warrants and acquiring new securities. These transactions...

    Kalkine Media•9/26/26•Somewhat-Bullish

    Form 4 Celularity Inc For: 25 September

    This article reports that a Form 4 filing for Celularity Inc. (CELU) was submitted on September 25. The stock symbol CELU showed a 4.55% increase. The piece provides no further details regarding the content of the Form...

    Investing.com India•9/25/26•Neutral

    1,177,000 warrants came with a Celularity (CELU) note purchase by a 10% owner's trust.

    The Philip and Daniele Barach Family Trust, a 10% owner of Celularity Inc. (CELU), reported significant acquisitions and amendments to convertible notes and warrants on September 23...

    Stock Titan•9/25/26•Neutral

    CELU Valuation and Fair Value

    P/B
    -1.1x
    See GNG's fair value

    CELU Profitability: Margins, ROIC and FCF

    Gross margin
    65.4%
    Operating margin
    -263.5%
    Net margin
    0.0%
    ROE
    -6367.0%
    FCF margin
    -74.8%

    CELU Competitors

    CompanyTicker
    LAVA Therapeutics NVLVTX
    Xtant Medical Holdings IncXTNT
    Hyperion DeFi, Inc.HYPD
    INmune Bio IncINMB
    ImageneBio, Inc.IMA
    Serina Therapeutics IncSER
    Sensus Healthcare IncSRTS
    Rapid Micro Biosystems IncRPID

    Sector: Healthcare

    CELU Bull Case vs Bear Case

    Bear case

    • CELU beat EPS estimates in 37.5% of its last 8 reported quarters.
    • CELU's quarterly revenue changed -66.3% year over year.

    CELU Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -478.4%

    Frequently Asked Questions About CELU

    Does CELU pay dividends?

    Celularity Inc (CELU) does not currently pay a regular dividend.

    What is CELU's market cap?

    Celularity Inc (CELU) has a market capitalization of $46.08M with a current stock price of $1.33.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In